Antibody Recognition and Conformational Flexibility of a Plaque-Specific beta-Amyloid Epitope Modulated by Non-native Peptide Flanking Regions

dc.contributor.authorManea, Marilena
dc.contributor.authorKalászi, Adriándeu
dc.contributor.authorMezö, Gábordeu
dc.contributor.authorHorváth, Katadeu
dc.contributor.authorBodor, Andreadeu
dc.contributor.authorHorváth, Anikódeu
dc.contributor.authorFarkas, Ödöndeu
dc.contributor.authorPerczel, Andrásdeu
dc.contributor.authorPrzybylski, Michael
dc.contributor.authorHudecz, Ferencdeu
dc.date.accessioned2011-03-24T18:14:14Zdeu
dc.date.issued2008deu
dc.description.abstractHere we report on the synthesis, antibody binding, and QSAR studies of a series of linear and cyclic peptides containing a β-amyloid plaque-specific epitope (Aβ(4 10); FRHDSGY). In these constructs, two or three α-l-Ala, α-d-Ala, or β-Ala residues were introduced at both N- and C-termini of the epitope as non-native flanking sequences. Cyclization of the linear Aβ(4 10) epitope peptide resulted in reduced antibody binding. However, the antibody binding could be fully compensated by insertion of alanine flanks into the corresponding cyclic peptides. These results indicate that the modification of a β-amyloid plaque-specific epitope by combination of cyclization and flanking sequences could generate highly antigenic peptides compared to the native sequence. A novel 3D QSAR method, which explicitly handles conformational flexibility, was developed for the case of such molecular libraries. This method led to the prediction of the binding conformation for the common FRHDSGY sequence.eng
dc.description.versionpublished
dc.format.mimetypeapplication/pdfdeu
dc.identifier.citationFirst publ. in: Journal of medicinal chemistry ; 51 (2008), 5. - S. 1150-1161deu
dc.identifier.doi10.1021/jm070196e
dc.identifier.pmid18284185
dc.identifier.ppn310255759deu
dc.identifier.urihttp://kops.uni-konstanz.de/handle/123456789/9761
dc.language.isoengdeu
dc.legacy.dateIssued2009deu
dc.rightsAttribution-NonCommercial-NoDerivs 2.0 Generic
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.0/
dc.subject.ddc540deu
dc.titleAntibody Recognition and Conformational Flexibility of a Plaque-Specific beta-Amyloid Epitope Modulated by Non-native Peptide Flanking Regionseng
dc.typeJOURNAL_ARTICLEdeu
dspace.entity.typePublication
kops.citation.bibtex
@article{Manea2008Antib-9761,
  year={2008},
  doi={10.1021/jm070196e},
  title={Antibody Recognition and Conformational Flexibility of a Plaque-Specific beta-Amyloid Epitope Modulated by Non-native Peptide Flanking Regions},
  number={5},
  volume={51},
  issn={0022-2623},
  journal={Journal of medicinal chemistry},
  pages={1150--1161},
  author={Manea, Marilena and Kalászi, Adrián and Mezö, Gábor and Horváth, Kata and Bodor, Andrea and Horváth, Anikó and Farkas, Ödön and Perczel, András and Przybylski, Michael and Hudecz, Ferenc}
}
kops.citation.iso690MANEA, Marilena, Adrián KALÁSZI, Gábor MEZÖ, Kata HORVÁTH, Andrea BODOR, Anikó HORVÁTH, Ödön FARKAS, András PERCZEL, Michael PRZYBYLSKI, Ferenc HUDECZ, 2008. Antibody Recognition and Conformational Flexibility of a Plaque-Specific beta-Amyloid Epitope Modulated by Non-native Peptide Flanking Regions. In: Journal of medicinal chemistry. 2008, 51(5), pp. 1150-1161. ISSN 0022-2623. eISSN 1520-4804. Available under: doi: 10.1021/jm070196edeu
kops.citation.iso690MANEA, Marilena, Adrián KALÁSZI, Gábor MEZÖ, Kata HORVÁTH, Andrea BODOR, Anikó HORVÁTH, Ödön FARKAS, András PERCZEL, Michael PRZYBYLSKI, Ferenc HUDECZ, 2008. Antibody Recognition and Conformational Flexibility of a Plaque-Specific beta-Amyloid Epitope Modulated by Non-native Peptide Flanking Regions. In: Journal of medicinal chemistry. 2008, 51(5), pp. 1150-1161. ISSN 0022-2623. eISSN 1520-4804. Available under: doi: 10.1021/jm070196eeng
kops.citation.rdf
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/9761">
    <dc:rights>Attribution-NonCommercial-NoDerivs 2.0 Generic</dc:rights>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-03-24T18:14:14Z</dc:date>
    <dc:format>application/pdf</dc:format>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/29"/>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/52"/>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/9761/1/JMedChem_2008_Manea.pdf"/>
    <dc:contributor>Mezö, Gábor</dc:contributor>
    <dc:creator>Hudecz, Ferenc</dc:creator>
    <dc:creator>Przybylski, Michael</dc:creator>
    <dc:creator>Bodor, Andrea</dc:creator>
    <dc:creator>Kalászi, Adrián</dc:creator>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/9761/1/JMedChem_2008_Manea.pdf"/>
    <dcterms:rights rdf:resource="http://creativecommons.org/licenses/by-nc-nd/2.0/"/>
    <dc:contributor>Horváth, Anikó</dc:contributor>
    <dc:creator>Horváth, Anikó</dc:creator>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dc:contributor>Hudecz, Ferenc</dc:contributor>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/29"/>
    <dc:contributor>Manea, Marilena</dc:contributor>
    <dc:contributor>Bodor, Andrea</dc:contributor>
    <dc:creator>Farkas, Ödön</dc:creator>
    <dcterms:issued>2008</dcterms:issued>
    <dcterms:bibliographicCitation>First publ. in: Journal of medicinal chemistry ; 51 (2008), 5. - S. 1150-1161</dcterms:bibliographicCitation>
    <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/9761"/>
    <dc:creator>Perczel, András</dc:creator>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:creator>Manea, Marilena</dc:creator>
    <dc:contributor>Kalászi, Adrián</dc:contributor>
    <dc:creator>Horváth, Kata</dc:creator>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/52"/>
    <dc:language>eng</dc:language>
    <dc:contributor>Horváth, Kata</dc:contributor>
    <dc:creator>Mezö, Gábor</dc:creator>
    <dc:contributor>Farkas, Ödön</dc:contributor>
    <dc:contributor>Przybylski, Michael</dc:contributor>
    <dcterms:abstract xml:lang="eng">Here we report on the synthesis, antibody binding, and QSAR studies of a series of linear and cyclic peptides containing a β-amyloid plaque-specific epitope (Aβ(4 10); FRHDSGY). In these constructs, two or three α-l-Ala, α-d-Ala, or β-Ala residues were introduced at both N- and C-termini of the epitope as non-native flanking sequences. Cyclization of the linear Aβ(4 10) epitope peptide resulted in reduced antibody binding. However, the antibody binding could be fully compensated by insertion of alanine flanks into the corresponding cyclic peptides. These results indicate that the modification of a β-amyloid plaque-specific epitope by combination of cyclization and flanking sequences could generate highly antigenic peptides compared to the native sequence. A novel 3D QSAR method, which explicitly handles conformational flexibility, was developed for the case of such molecular libraries. This method led to the prediction of the binding conformation for the common FRHDSGY sequence.</dcterms:abstract>
    <dc:contributor>Perczel, András</dc:contributor>
    <dcterms:title>Antibody Recognition and Conformational Flexibility of a Plaque-Specific beta-Amyloid Epitope Modulated by Non-native Peptide Flanking Regions</dcterms:title>
  </rdf:Description>
</rdf:RDF>
kops.description.openAccessopenaccessgreen
kops.flag.knbibliographytrue
kops.identifier.nbnurn:nbn:de:bsz:352-opus-76622deu
kops.opus.id7662deu
kops.sourcefieldJournal of medicinal chemistry. 2008, <b>51</b>(5), pp. 1150-1161. ISSN 0022-2623. eISSN 1520-4804. Available under: doi: 10.1021/jm070196edeu
kops.sourcefield.plainJournal of medicinal chemistry. 2008, 51(5), pp. 1150-1161. ISSN 0022-2623. eISSN 1520-4804. Available under: doi: 10.1021/jm070196edeu
kops.sourcefield.plainJournal of medicinal chemistry. 2008, 51(5), pp. 1150-1161. ISSN 0022-2623. eISSN 1520-4804. Available under: doi: 10.1021/jm070196eeng
relation.isAuthorOfPublicationfe14022b-4899-41a3-a7ca-68b214bea2d9
relation.isAuthorOfPublication0dbb5afb-68a9-4364-be03-ca30dec62041
relation.isAuthorOfPublication.latestForDiscoveryfe14022b-4899-41a3-a7ca-68b214bea2d9
source.bibliographicInfo.fromPage1150
source.bibliographicInfo.issue5
source.bibliographicInfo.toPage1161
source.bibliographicInfo.volume51
source.identifier.eissn1520-4804
source.identifier.issn0022-2623
source.periodicalTitleJournal of medicinal chemistry

Dateien

Originalbündel

Gerade angezeigt 1 - 1 von 1
Vorschaubild nicht verfügbar
Name:
JMedChem_2008_Manea.pdf
Größe:
1.26 MB
Format:
Adobe Portable Document Format
JMedChem_2008_Manea.pdf
JMedChem_2008_Manea.pdfGröße: 1.26 MBDownloads: 733